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Abstract
Background: Epidemiological studies have indicated a higher incidence of breast and gastric cancer in patients
with nonsyndromic cleft lip with or without cleft palate (NSCL ± P) and their relatives, which can be based on
similar genetic triggers segregated within family with NSCL ± P.
Methods: This multicenter study evaluated the association of 9 single nucleotide polymorphisms (SNP) in AXIN2
and CDH1, representing genes consistently altered in breast and gastric tumors, with NSCL ± P in 223 trios
(father, mother and patient with NSCL ± P) by transmission disequilibrium test (TDT).
Results: Our results showed that the minor A allele of rs7210356 (p = 0.01) and the T-G-G-A-G haplotype formed by
rs7591, rs7210356, rs4791171, rs11079571 and rs3923087 SNPs (p = 0.03) in AXIN2 were significantly under-
transmitted to patients with NSCL ± P. In CDH1 gene, the C-G-A-A and A-G-A-G haplotypes composed by rs16260,
rs9929218, rs7186053 and rs4783573 polymorphisms were respectively over-transmitted (p = 0.01) and under-transmitted
(p = 0.008) from parents to the children with NSCL ± P.
Conclusions: The results suggest that polymorphic variants in AXIN2 and CDH1 may be associated with NSCL ± P
susceptibility, and reinforce the putative link between cancer and oral clefts.
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Background
Oral clefts are the most common congenital craniofacial
abnormalities in humans [1, 2]. About 70% of cases
occur as a nonsyndromic form, and the remaining 30%
are associated with Mendelian disorders or chromo-
somal, teratogenic and sporadic conditions [3, 4]. Non-
syndromic oral clefts are traditionally divided in cleft lip
only (NSCLO), cleft lip and palate (NSCLP) and cleft
palate only (NSCPO), however, as there are similarities
in both epidemiologic features and embryologic timing
for both NSCLO and NSCLP, they are considered
variants of the same defect and grouped together to
form the group cleft lip with or without cleft palate
(NSCL ± P) [5, 6]. Oral clefts affect approximately 1 in
500–2000 live births, with variable prevalence around
the world, often attributed to ethnic and environmental
differences. American and Asian populations have a high
prevalence (1:500), populations from Europe have inter-
mediate prevalence (1:1000) and the lowest prevalence is
observed in Africans and their descendants (1:2500) [7].
Previous studies have revealed that NSCL ± P etiology is
dependent of interactions between environmental and
genetic risk factors [8, 9]. In fact, epidemiological studies
and analysis of animal models have provided evidences
of a putative participation of agrotoxics, cigarette smoking,
consumption of alcohol and drugs, malnutrition and some
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viral infections in etiology of NSCL ± P [10, 11]. Genetic
linkage and genome-wide association studies (GWAS)
have described several genes and loci in association with
NSCL ± P, including IRF6, VAX1, MSX1, FOXE1, MYH9,
MAFB, ABCA4, BMP4, FGFR2, TGFA, TGFB3, MTHFR,
GSTT1, PDGFC, FGF8, PVRL1, SUMO1, CRISPLD2 and
the regions 8q24 and 17q22 [1, 12, 13].
Epidemiological studies have shown a high risk of oral
clefts in families with cancer, while others have provided
consistent data about increased risk of cancer in patients
with oral cleft and their relatives [14–18]. This associ-
ation has been explicated because specific cancers,
including those of breast and stomach, and NSCL ± P
may share similar genetic etiology [14, 19–21]. The
Wingless/integrase-1 (WNT) signaling pathway is an
evolutionarily conserved pathway with major roles in cell
migration, cell polarity, cell fate determination and
organogenesis during embryonic development, including
orofacial morphogenesis [22–24], and aberrant expres-
sion of several WNT family members is common in
cancers [25, 26]. The canonical WNT signaling is
mediated by the translocation of β-catenin to the nucleus,
where it activates transcription of several factors regulat-
ing proliferation and differentiation, while noncanonical
WNT signaling is β-catenin independent [27].
The axis inhibition protein 2 (AXIN2), a member of
the WNT pathway, is associated with the development
and progression of breast cancers [21, 28], and polymor-
phisms in AXIN2 are associated with increased risk for
breast cancer in premenopausal women [29]. E-cadherin,
encoded by the CDH1 (cadherin-1) gene, is a transmem-
brane glycoprotein playing a crucial role in maintaining
cell-to-cell adhesion [30]. E-cadherin has been reported to
be a tumor suppressor and to be downregulated in gastric
cancer [31–33]. Germline CDH1 mutations confer an in-
creased risk of developing both gastric and breast cancer
[34]. Genetics studies revealed that polymorphic variants
in AXIN2 and CDH1 are risk factors for NSCL ± P and
tooth agenesis [35–40]. In this study, we postulated that
single nucleotide polymorphisms (SNP) in genes associ-
ated with breast and gastric pathogenesis (AXIN2 and
CDH1) might be related to the risk of NSCL ± P. Thus, we
evaluated the association of 9 SNPs in CDH1 and AXIN2
with the risk of NSCL ± P using a family-based study
design (case-parent trios). This design has the advantage
of bypass problems with population stratification. Indeed,
the main disadvantage of case-control studies, the most
common approach in genetic studies, is unaccounted
population admixture with a possible threat to the validity
of the obtained results.
Methods
This study included samples from four Brazilian
states: Minas Gerais state (Center for Rehabilitation
of Craniofacial Anomalies, Dental School, University
of José Rosário Vellano, Alfenas-MG), located in the
Southeastern region of Brazil, Paraná state (Association of
Carrier of Lip and Palate Cleft-APOFILAB, Cascavel-PR),
in the Southern region, Paraíba state (University Hospital
of Lauro Wanderley-HULW, João Pessoa-PB) and Bahia
state (Santo Antonio Hospital, Salvador-BA), which are lo-
cated in the Northeast region. The cohort was composed
of 223 trios composed of one affected offspring and two
healthy parents. Information on demographic characteris-
tics, including gender and race, and family history of oral
cleft and cancer were collected through direct interview of
the patients and/or mothers (Additional file 1: Table S1).
All patients were diagnosed independently and screened
for the presence of associated anomalies or syndromes
by the team of specialists from each center, and only
patients with the nonsyndromic form were included.
The NSCL ± P was classified with the incisive foramen
as reference [41].
The genomic DNA was isolated from buccal mucosa
cells obtained by mouthwash with a 3% sucrose solution,
using a salting-out protocol previously described [42].
SNPs, including rs16260, rs9929218, rs7186053 and
rs4783573 in CDH1 and rs7591, rs7210356, rs4791171,
rs11079571 and rs3923087 in AXIN2 (Table 1), were ge-
notyped using the Taqman genotyping assay (assay-on-de-
mand, Applied Biosystems). Genotyping analyses were
randomly repeated in 10% of the samples, and the con-
cordance rate was 100%. These SNPs were selected based
on their minor allele frequencies (www.ncbi.nlm.nih.gov)
and because they were described as risk factors for oral
cleft and breast and gastric cancer [29, 37, 39, 40, 43–46].
The study was approved by the ethics review board of
each of the centers or hospitals affiliated with the collab-
orative study. Written informed consent was obtained
from the parents or guardians and/or the participants.
For allele transmission analysis, the transmission
disequilibrium test (TDT) was performed with the aid of
Table 1 Characteristics of the single-nucleotide polymorphisms
(SNPs)
SNP Gene Chromosome Location Position Alleles
rs16260 CDH1 16 promoter 68,737,131 C/A
rs9929218 CDH1 16 intron 68,787,043 G/A
rs7186053 CDH1 16 intron 68,805,390 G/A
rs4783573 CDH1 16 intron 68,806,685 G/A
rs7591 AXIN2 17 3’ UTR 65,528,964 A/T
rs7210356 AXIN2 17 intron 65,532,832 G/A
rs4791171 AXIN2 17 intron 65,545,379 A/G
rs11079571 AXIN2 17 intron 65,552,563 G/A
rs3923087 AXIN2 17 intron 65,553,143 A/G
Risk alleles in bold
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the FBAT (Family Based Association Test) software. The
haplotype-based analysis was conducted using the HBAT
(Haplotype-Based Association Test) command in FBAT
software. These tests are intended to verify the
genotype-phenotype association from the unbalanced
transmission of the alleles and haplotypes from healthy
parents to affected children. The Z-score value measures
the deviation from the null hypothesis, and positive Z-
score indicates that the allele is over-transmitted to the
affected offspring (is a risk factor), whereas a negative Z-
score indicates under-transmission to affected offspring
(is a protective factor). The pair-wise linkage disequilib-
rium (LD) was estimated from the combined data of all
trios calculating D’ and r2 using the using Haploview
software (v4.2). The p value of <0.05 was considered
statistically significant.
Results
Our results showed that the minor A allele of AXIN2
rs7210356 was significantly under-transmitted to pa-
tients with NSCL ± P (p = 0.01) (Table 2). HBAT analyses
showed the C-G-A-A and A-G-A-G haplotypes formed
by rs16260, rs9929218, rs7186053 and rs4783573 in
CDH1 were significantly transmitted from parents to the
children with NSCL ± P (p = 0.01 and p = 0.008,
respectively) (Table 3). In AXIN2 gene, the frequency
of the T-G-G-A-G haplotype formed by rs7591,
rs7210356, rs4791171, rs11079571 and rs3923087 SNPs
was also under-transmitted to patients with NSCL ± P
(p = 0.03) (Table 4).
The LD pattern of the SNPs examined is displayed in
Table 5. The LD values between CDH1 SNPs were low,
whereas AXIN2 SNPs rs7591, rs7210256 and rs4791171
were in complete linkage disequilibrium (rs7591 and
rs7210356: D’ = 0.97 and r2 = 0.10, rs7591 and
rs4791171: D’ = 0.93 and r2 = 0.68, rs7210356 and
rs4791171: D’ = 0.95 and r2 = 0.12).
Discussion
Although the exact environmental and genetic risk
factors associated with NSCL ± P remains unclear, the
understanding of the genetic mechanisms involved in
this malformation are evolving. Interestingly, recent
studies have demonstrated a relationship between
congenital malformations and malignancies, and genetic
alterations in AXIN2 and CDH1 are associated with both
NSCL ± P [37, 39, 47] and cancer of breast and gastric
[21, 28, 29, 31–34]. In this study we explored the clinical
relevance of breast and gastric cancer-associated poly-
morphisms in AXIN2 and CDH1 with NSCL ± P risk in
the Brazilian population. Our results suggest that the
AXIN2 rs7210356 SNP is associated with the occurrence
of NSCL ± P in the investigated population. This SNP
was associated with breast cancer risk in premenopausal
Table 2 Transmission disequilibrium test (TDT) of the single-
nucleotide polymorphisms (SNPs) in nonsyndromic cleft lip with
or without cleft palate (NSCL ± P) trios
SNP MAF Number of
families
T/NT Z score p value
rs16260 0.295 135 86/49 1.00 0.31
rs9929218 0.271 133 78/55 -0.46 0.64
rs7186053 0.329 134 84/50 -0.98 0.32
rs4783573 0.523 146 103/43 -1.39 0.16
rs7591 0.543 154 121/33 0.55 0.58
rs7210356 0.081 54 34/20 -2.47 0.01
rs4791171 0.616 139 118/21 0.36 0.71
rs11079571 0.215 99 50/49 -1.68 0.09
rs3923087 0.606 136 116/20 0.00 1.00
MAF: minor allele frequency, T/NT: transmission/non-transmission counts
Table 3 Haplotype family-based association test for CDH1 rs16260,
rs9929218, rs7186053 and rs4783573 performed using HBAT
Haplotype* Number of
families
Frequency Z score p value
C-G-G-G 119 0.336 0.73 0.46
C-G-G-A 94 0.216 0.80 0.42
A-A-A-A 82 0.185 -0.71 0.47
C-G-A-A 42 0.064 -2.48 0.01
A-G-A-G 22 0.032 2.66 0.008
C-A-G-G 17 0.031 -0.07 0.94
C-G-A-G 21 0.029 -1.20 0.23
A-A-G-A 20 0.025 0.64 0.52
C-A-G-A 16 0.018 -0.96 0.34
A-A-G-G 12 0.015 -0.14 0.88
A-G-G-G 10 0.013 -0.31 0.76
A-A-A-G 12 0.010 1.12 0.26
*Sequence: rs16260, rs9929218, rs7186053 and rs4783573
Table 4 Haplotype family-based association test for AXIN2 rs7591,




Frequency Z score p value
T-G-G-G-G 96 0.486 1.45 0.15
A-G-A-G-A 77 0.158 0.75 0.45
A-G-A-A-A 62 0.121 0.02 0.98
A-G-G-G-G 30 0.052 0.35 0.73
A-A-A-A-A 17 0.031 -1.89 0.06
T-G-G-G-G 20 0.030 0.15 0.88
A-A-A-G-G 15 0.029 -0.37 0.71
A-G-A-G-G 14 0.019 -1.39 0.16
T-G-G-A-G 12 0.016 -2.08 0.03
A-G-G-A-G 11 0.013 0.39 0.69
*Sequence: rs7591, rs7210356, rs4791171, rs11079571 and rs3923087
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but not in postmenopausal women [29]. The impact of
the rs7210356 polymorphism in lip and palate develop-
ment is unclear and our findings are of interest espe-
cially to understand this association. Haplotype analysis
showed that five SNPs in AXIN2 (rs7591, rs7210356,
rs4791171, rs11079571 and rs3923087) were associated
with occurrence of NSCL ± P. Previously studies revealed
that the both rs7591 and rs3923087 were associated with
NSCL ± P and tooth agenesis [37, 46].
CDH1 haplotypes composed by rs16260, rs9929218,
rs7186053 and rs4783573 were associated with NSCL ±
P in our study population. Many reports showed that
rs16260 is associated with the development of gastric
cancer [45, 48], but it is controversial its association with
craniofacial development [39, 40]. Similarly, rs9929218
was shown to have a borderline association with unilat-
eral NSCL/P in Brazilian population [37] as well as the
haplotype composed of rs9929218, rs7186053, rs4783573
and rs16958383 to NSCL/P in the population of Warsaw
[40]. CDH1 plays a key role in cell adhesion, which is
vital to normal development, including craniofacial
morphogenesis and palatal fusion [49]. Thus, further
examination of haplotypes in CDH1 gene, including
rs16260, rs9929218, rs7186053 and rs4783573, is needed
to identify the molecular relevant causes.
Conclusions
In summary, little is known about the relationship
between AXIN2 and CDH1 genes and oral clefts in
humans. In the present study identified one SNP and
one haplotype in AXIN2 gene and two haplotypes in
CDH1 gene significantly associated with NSCL ± P
susceptibility in Brazilian population. Except the C-G-A-A
haplotype formed by rs16260, rs9929218, rs7186053 and
rs4783573 in CDH1 gene which was associated with
increased risk of NSCL ± P, the others haplotypes in
AXIN2 and CDH1 genes, as well as the rs7210356 allele
alone, were associated in a protective manner to NSCL ±
P. Though, the population size in our study is small and
the significant results need to be confirmed in larger
groups with known family history of breast and gastric
cancer to better understand the interactions between
AXIN2 and CDH1 genes in the development of NSCL ± P.
Additional file
Additional file 1: Table S1. Clinical and epidemiological characteristics
of patients with nonsyndromic cleft lip with or without cleft palate.
(DOCX 14 kb)
Abbreviations
AXIN2: Axis inhibition protein 2; CDH1: Cadherin-1; FBAT: Family based
association test; HBAT: Haplotype-based association test; MAF: Minor allele
frequency; NSCL ± P: Nonsyndromic cleft lip with or without cleft palate;
NSCLO: Nonsyndromic cleft lip only; NSCLP: Nonsyndromic cleft lip and
palate; NSCPO: Nonsyndromic cleft palate only; OR: Odds ratio; SNP: Single
nucleotide polymorphism; T/NT: Transmission/non-transmission counts;
TDT: Transmission disequilibrium test
Acknowledgments
The authors thank all the study subjects and research staff who participated
in this work.
Funding
This work was supported by grants from Research Support Foundation of
Minas Gerais – FAPEMIG, National Council for Scientific and Technological
Development – CNPq, Coordination of Improvement of High Education
Personnel (CAPES) and Procad/Casadinho.
Availability of data and materials
All data and materials supporting the conclusions of this article are included
within the article and its Additional file 1: Table S1.
Authors’ contributions
RC and HMJ designed and supervised the study. RAM, SNA, DRM, MSO, SRR,
DCP, HSM and VOD recruited participants, analyzed and interpreted the data,
drafted and revised the manuscript; RAM and EMF performed laboratory
experiments, analyzed and interpreted the data, assisted with drafting the
manuscript. All authors have read and approved the final version of the
manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Participants were recruited from the Center for Rehabilitation of Craniofacial
Anomalies (located in the Southeastern region of Brazil), Association of
Carrier of Lip and Palate Cleft-APOFILAB (located in the South of Brazil),
University Hospital of Lauro Wanderley-HULW and Santo Antonio Hospital,
which are located in the Northeastern region. This study was approved by
the institutional review board of each participating hospitals. Written consents
were obtained from each participant.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Table 5 Linkage disequilibrium analysis of the CDH1 (A) and
AXIN2 (B) SNP. D’ coefficient is above the diagonal and r’ is below
diagonal
A
rs16260 rs9929218 rs7186053 rs4783573
rs16260 - 0.77 0.69 0.49
rs9929218 0.55 - 0.57 0.59
rs7186053 0.41 0.26 - 0.48
rs4783573 0.09 0.12 0.10 -
B
rs7591 rs7210356 rs4791171 rs11079571 rs3923087
rs7591 - 0.97 0.93 0.78 0.77
rs7210356 0.10 - 0.95 0.35 0.27
rs4791171 0.68 0.12 - 0.74 0.79
rs11079571 0.20 0.04 0.23 - 0.86
rs3923087 0.47 0.01 0.61 0.31 -
Machado et al. BMC Medical Genetics  (2017) 18:39 Page 4 of 6
Author details
1Department of Oral Diagnosis, Dental School, State University of Campinas,
Piracicaba, São Paulo, Brazil. 2Stomatology Clinic, Dental School, State
University of Montes Claros, Montes Claros, Minas Gerais, Brazil. 3School of
Dentistry, Federal University of Juiz de Fora, Governador Valadares, Minas
Gerais, Brazil. 4Center for Rehabilitation of Craniofacial Anomalies, University
of José Rosário Vellano, Alfenas, Minas Gerais, Brazil. 5Department of Basic
Science, Bahiana School of Medicine and Public Health, Salvador, Bahia,
Brazil. 6Molecular Biology Departament, Federal University of Paraíba, João
Pessoa, Paraíba, Brazil. 7Department of Physiotherapy, State University of
Western Paraná, Cascavel, Paraná, Brazil.
Received: 4 August 2016 Accepted: 3 March 2017
References
1. Dixon MJ, Marazita ML, Beaty TH, Murray JC. Cleft lip and palate: understanding
genetic and environmental influences. Nat Rev Genet. 2011;12(3):167–78.
2. Marazita ML, Lidral AC, Murray JC, Field LL, Maher BS, Goldstein McHenry T,
Cooper ME, Govil M, Daack-Hirsch S, Riley B, Jugessur A, Felix T, Morene L,
Mansilla MA, Vieira AR, Doheny K, Pugh E, Valencia-Ramirez C, Arcos-Burgos
M. Genome scan, fine-mapping, and candidate gene analysis of non-
syndromic cleft lip with or without cleft palate reveals phenotype-specific
differences in linkage and association results. Hum Hered. 2009;68(3):151–70.
3. Meng L, Bian Z, Torensma R, Von den Hoff JW. Biological mechanisms in
palatogenesis and cleft palate. J Dent Res. 2009;88(1):22–33.
4. Mangold E, Ludwig KU, Nothen MM. Breakthroughs in the genetics of
orofacial clefting. Trends Mol Med. 2011;17(12):725–33.
5. Harville EW, Wilcox AJ, Lie RT, Vindenes H, Abyholm F. Cleft lip and palate
versus cleft lip only: are they distinct defects? Am J Epidemiol.
2005;162(5):448–53.
6. Grosen D, Chevrier C, Skytthe A, Bille C, Molsted K, Sivertsen A, Murray JC,
Christensen K. A cohort study of recurrence patterns among more than
54,000 relatives of oral cleft cases in Denmark: support for the multifactorial
threshold model of inheritance. J Med Genet. 2010;47(3):162–8.
7. Murthy J, Bhaskar L. Current concepts in genetics of nonsyndromic clefts.
Indian J Plast Surg. 2009;42(1):68–81.
8. Machado RA, Moreira HS, de Aquino SN, Martelli-Junior H, de Almeida Reis
SR, Persuhn DC, Wu T, Yuan Y, Coletta RD. Interactions between RAD51
rs1801321 and maternal cigarette smoking as risk factor for nonsyndromic
cleft lip with or without cleft palate. Am J Med Genet A. 2016;170(2):536–9.
9. Wu T, Schwender H, Ruczinski I, Murray JC, Marazita ML, Munger RG,
Hetmanski JB, Parker MM, Wang P, Murray T, Taub M, Li S, Redett RJ, Fallin
MD, Liang KY, Wu-Chou YH, Chong SS, Yeow V, Ye X, Wang H, Huang S,
Jabs EW, Shi B, Wilcox AJ, Jee SH, Scott AF, Beaty TH. Evidence of
gene-environment interaction for two genes on chromosome 4 and
environmental tobacco smoke in controlling the risk of nonsyndromic cleft
palate. PLoS One. 2014;9(2):e88088.
10. James A, Oluwatosin B, Njideka G, Babafemi BOG, Olufemi D, Leo R,
Folorunso I, Phylis OO. Cleft palate in hiv-exposed newborns of mothers on
highly active antiretroviral therapy. Oral Surg. 2014;7 Suppl 1:102–6.
11. Figueiredo JC, Ly S, Magee KS, Ihenacho U, Baurley JW, Sanchez-Lara PA,
Brindopke F, Nguyen TH, Nguyen V, Tangco MI, Giron M, Abrahams T, Jang
G, Vu A, Zolfaghari E, Yao CA, Foong A, DeClerk YA, Samet JM, Magee W.
Parental risk factors for oral clefts among Central Africans, Southeast Asians,
and Central Americans. Birth Defects Res A Clin Mol Teratol.
2015;103(10):863–79.
12. Yuan Q, Blanton SH, Hecht JT. Genetic causes of nonsyndromic cleft lip with
or without cleft palate. Adv Otorhinolaryngol. 2011;70:107–13.
13. Mehrotra D. Genomic expression in non syndromic cleft lip and palate
patients: a review. J Oral Biol Craniofac Res. 2015;5(2):86–91.
14. Taioli E, Ragin C, Robertson L, Linkov F, Thurman NE, Vieira AR. Cleft lip
and palate in family members of cancer survivors. Cancer Invest.
2010;28(9):958–62.
15. Jindal A, Vieira AR. Family history of cleft lip and palate in subjects
diagnosed with leukemia. Am J Med Genet A. 2012;158A(3):678–9.
16. Zhu JL, Basso O, Hasle H, Winther JF, Olsen JH, Olsen J. Do parents of
children with congenital malformations have a higher cancer risk? a
nationwide study in Denmark. Br J Cancer. 2002;87(5):524–8.
17. Vieira AR, Khaliq S, Lace B. Risk of cancer in relatives of children born with
isolated cleft lip and palate. Am J Med Genet A. 2012;158A(6):1503–4.
18. Goncalves E, Martelli DR, Coletta RD, Vieira AR, Caldeira AP, Martelli Jr H.
Risk of leukemia in first degree relatives of patients with nonsyndromic cleft
lip and palate. Braz Oral Res. 2014;28(1):1–3.
19. Frebourg T, Oliveira C, Hochain P, Karam R, Manouvrier S, Graziadio C,
Vekemans M, Hartmann A, Baert-Desurmont S, Alexandre C, Lejeune
Dumoulin S, Marroni C, Martin C, Castedo S, Lovett M, Winston J, Machado
JC, Attié T, Jabs EW, Cai J, Pellerin P, Triboulet JP, Scotte M, Le Pessot F,
Hedouin A, Carneiro F, Blayau M, Seruca R. Cleft lip/palate and CDH1/E-
cadherin mutations in families with hereditary diffuse gastric cancer.
J Med Genet. 2006;43(2):138–42.
20. Cavallaro U, Dejana E. Adhesion molecule signalling: not always a sticky
business. Nat Rev Mol Cell Biol. 2011;12(3):189–97.
21. Li S, Wang C, Liu X, Hua S. The roles of AXIN2 in tumorigenesis and
epigenetic regulation. Fam Cancer. 2015;14(2):325–31.
22. Mani P, Jarrell A, Myers J, Atit R. Visualizing canonical Wnt signaling during
mouse craniofacial development. Dev Dyn. 2010;239(1):354–63.
23. Chiquet BT, Blanton SH, Burt A, Ma D, Stal S, Mulliken JB, Hecht JT. Variation
in WNT genes is associated with non-syndromic cleft lip with or without
cleft palate. Hum Mol Genet. 2008;17(14):2212–8.
24. Lu YP, Han WT, Liu Q, Li JX, Li ZJ, Jiang M, Xu W. Variations in WNT3 gene
are associated with incidence of non-syndromic cleft lip with or without
cleft palate in a northeast Chinese population. Genet Mol Res.
2015;14(4):12646–53.
25. Galamb O, Kalmár A, Péterfia B, Csabai I, Bodor A, Ribli D, Krenács T, Patai ÁV,
Wichmann B, Barták BK, Tóth K, Valcz G, Spisák S, Tulassay Z, Molnár B.
Aberrant DNA methylation of WNT pathway genes in the development
and progression of CIMP-negative colorectal cancer. Epigenetics. 2016;
11(8):588–602.
26. Chan DW, Mak CS, Leung TH, Chan KK, Ngan HY. Down-regulation of Sox7
is associated with aberrant activation of Wnt/b-catenin signaling in
endometrial cancer. Oncotarget. 2012;3(12):1546–56.
27. Baarsma HA, Konigshoff M, Gosens R. The WNT signaling pathway from
ligand secretion to gene transcription: molecular mechanisms and
pharmacological targets. Pharmacol Ther. 2013;138(1):66–83.
28. Wang SH, Li N, Wei Y, Li QR, Yu ZP. beta-catenin deacetylation is essential
for WNT-induced proliferation of breast cancer cells. Mol Med Rep.
2014;9(3):973–8.
29. Wang X, Goode EL, Fredericksen ZS, Vierkant RA, Pankratz VS, Liu-Mares W,
Rider DN, Vachon CM, Cerhan JR, Olson JE, Couch FJ. Association of genetic
variation in genes implicated in the beta-catenin destruction complex with
risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(8):2101–8.
30. Paredes J, Figueiredo J, Albergaria A, Oliveira P, Carvalho J, Ribeiro AS,
Caldeira J, Costa AM, Simões-Correia J, Oliveira MJ, Pinheiro H, Pinho SS,
Mateus R, Reis CA, Leite M, Fernandes MS, Schmitt F, Carneiro F, Figueiredo
C, Oliveira C, Seruca R. Epithelial E- and P-cadherins: role and clinical
significance in cancer. Biochim Biophys Acta. 2012;1826(2):297–311.
31. Liu X, Chu KM. E-cadherin and gastric cancer: cause, consequence, and
applications. Biomed Res Int. 2014;2014:637308.
32. Jiang B, Zhu K, Shao H, Bao C, Ou J, Sun W. Lack of association between the
CDH1 polymorphism and gastric cancer susceptibility: a meta-analysis.
Sci Rep. 2015;5:7891.
33. Li YL, Tian Z, Zhang JB, Fu BY. CDH1 promoter polymorphism and stomach
cancer susceptibility. Mol Biol Rep. 2012;39(2):1283–6.
34. van der Post RS, Vogelaar IP, Carneiro F, Guilford P, Huntsman D,
Hoogerbrugge N, Caldas C, Schreiber KE, Hardwick RH, Ausems MG,
Bardram L, Benusiglio PR, Bisseling TM, Blair V, Bleiker E, Boussioutas A,
Cats A, Coit D, DeGregorio L, Figueiredo J, Ford JM, Heijkoop E, Hermens R,
Humar B, Kaurah P, Keller G, Lai J, Ligtenberg MJ, O’Donovan M, Oliveira C,
Pinheiro H, Ragunath K, Rasenberg E, Richardson S, Roviello F, Schackert H,
Seruca R, Taylor A, Ter Huurne A, Tischkowitz M, Joe ST, van Dijck B, van
Grieken NC, van Hillegersberg R, van Sandick JW, Vehof R, van Krieken JH,
Fitzgerald RC. Hereditary diffuse gastric cancer: updated clinical guidelines
with an emphasis on germline CDH1 mutation carriers. J Med Genet.
2015;52(6):361–74.
35. Han Y, Zhou L, Ma L, Li D, Xu M, Yuan H, Ma J, Zhang W, Jiang H, Wu Y,
Wang L, Pan Y. The axis inhibition protein 2 polymorphisms and non-
syndromic orofacial clefts susceptibility in a Chinese Han population.
J Oral Pathol Med. 2014;43(7):554–60.
36. Letra A, Bjork B, Cooper ME, Szabo-Rogers H, Deleyiannis FW, Field LL,
Czeizel AE, Ma L, Garlet GP, Poletta FA, Mereb JC, Lopez-Camelo JS, Castilla
EE, Orioli IM, Wendell S, Blanton SH, Liu K, Hecht JT, Marazita ML, Vieira AR,
Machado et al. BMC Medical Genetics  (2017) 18:39 Page 5 of 6
Silva RM. Association of AXIN2 with non-syndromic oral clefts in multiple
populations. J Dent Res. 2012;91(5):473–8.
37. Letra A, Menezes R, Granjeiro JM, Vieira AR. AXIN2 and CDH1 polymorphisms,
tooth agenesis, and oral clefts. Birth Defects Res A Clin Mol Teratol.
2009;85(2):169–73.
38. Bureau A, Parker MM, Ruczinski I, Taub MA, Marazita ML, Murray JC,
Mangold E, Noethen MM, Ludwig KU, Hetmanski JB, Bailey-Wilson JE, Cropp CD, Li
Q, Szymczak S, Albacha-Hejazi H, Alqosayer K, Field LL, Wu-Chou YH, Doheny KF,
Ling H, Scott AF, Beaty TH. Whole exome sequencing of distant relatives in
multiplex families implicates rare variants in candidate genes for oral clefts.
Genetics. 2014;197(3):1039–44.
39. Song Y, Zhang S. Association of CDH1 promoter polymorphism and the risk
of non-syndromic orofacial clefts in a Chinese Han population. Arch Oral
Biol. 2011;56(1):68–72.
40. Hozyasz KK, Mostowska A, Wojcicki P, Lasota A, Offert B, Balcerek A, Dunin-
Wilczyńska I, Jagodziński PP. Nucleotide variants of the cancer predisposing
gene CDH1 and the risk of non-syndromic cleft lip with or without cleft
palate. Fam Cancer. 2014;13(3):415–21.
41. Spina V, Psillakis JM, Lapa FS, Ferreira MC. Classification of cleft lip and cleft
palate. Suggested changes. Rev Hosp Clin Fac Med Sao Paulo. 1972;27(1):5–6.
42. Aidar M, Line SR. A simple and cost-effective protocol for DNA isolation
from buccal epithelial cells. Braz Dent J. 2007;18(2):148–52.
43. Alanazi MS, Parine NR, Shaik JP, Alabdulkarim HA, Ajaj SA, Khan Z.
Association of single nucleotide polymorphisms in Wnt signaling pathway
genes with breast cancer in Saudi patients. PLoS One. 2013;8(3):e59555.
44. Jing H, Dai F, Zhao C, Yang J, Li L, Kota P, Mao L, Xiang K, Zheng C, Yang J.
Association of genetic variants in and promoter hypermethylation of CDH1
with gastric cancer: a meta-analysis. Medicine (Baltimore). 2014;93(19):e107.
45. Zhan Z, Wu J, Zhang JF, Yang YP, Tong S, Zhang CB, Li J, Yang XW, Dong W.
CDH1 gene polymorphisms, plasma CDH1 levels and risk of gastric cancer in a
Chinese population. Mol Biol Rep. 2012;39(8):8107–13.
46. Mostowska A, Hozyasz KK, Wojcicki P, Lasota A, Dunin-Wilczynska I,
Jagodzinski PP. Association of DVL2 and AXIN2 gene polymorphisms with
cleft lip with or without cleft palate in a Polish population. Birth Defects Res
A Clin Mol Teratol. 2012;94(11):943–50.
47. Menezes R, Marazita ML, Goldstein McHenry T, Cooper ME, Bardi K, Brandon C,
Letra A, Martin RA, Vieira AR. AXIS inhibition protein 2, orofacial clefts and a
family history of cancer. J Am Dent Assoc. 2009;140(1):80–4.
48. Al-Moundhri MS, Al-Khanbashi M, Al-Kindi M, Al-Nabhani M, Burney IA,
Al-Farsi A, Al-Bahrani B. Association of E-cadherin (CDH1) gene polymorphisms
and gastric cancer risk. World J Gastroenterol. 2010;16(27):3432–6.
49. Kerrigan JJ, Mansell JP, Sengupta A, Brown N, Sandy JR. Palatogenesis and
potential mechanisms for clefting. J R Coll Surg Edinb. 2000;45(6):351–8.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Machado et al. BMC Medical Genetics  (2017) 18:39 Page 6 of 6
